These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL. World J Gastroenterol; 2013 Oct 21; 19(39):6656-64. PubMed ID: 24151396 [Abstract] [Full Text] [Related]
4. Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma. El-Adly TZ, Kamal S, Selim H, Botros S. Cent Eur J Immunol; 2016 Oct 21; 41(3):268-272. PubMed ID: 27833444 [Abstract] [Full Text] [Related]
5. The MIF -173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Xue Y, Xu H, Rong L, Lu Q, Li J, Tong N, Wang M, Zhang Z, Fang Y. Leuk Res; 2010 Oct 21; 34(10):1282-6. PubMed ID: 20447688 [Abstract] [Full Text] [Related]
7. -173G/C polymorphism in the promoter of MIF is associated with hepatitis B virus infection in a Chinese Han population. Wang ZS, Yin CC, Han S, Jiang FL, Guo WG, Wu LQ, Liu SH. Genet Mol Res; 2015 Jul 28; 14(3):8532-8. PubMed ID: 26345783 [Abstract] [Full Text] [Related]
9. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M. Am J Respir Crit Care Med; 2004 May 01; 169(9):1014-8. PubMed ID: 14962818 [Abstract] [Full Text] [Related]
10. Macrophage migration inhibitory factor gene promoter polymorphism (-173G/C SNP) determines host susceptibility and severity of leptospirosis. Sumaiya K, Natarajaseenivasan K. Microb Pathog; 2022 Mar 01; 164():105445. PubMed ID: 35151822 [Abstract] [Full Text] [Related]
14. Lack of association between MIF gene -173G>C polymorphism with multiple sclerosis. Cevik B, Yigit S, Karakus N, Aksoy D, Ates O, Kurt S. In Vivo; 2015 Mar 01; 29(1):71-6. PubMed ID: 25600533 [Abstract] [Full Text] [Related]
15. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile. Baños-Hernández CJ, Navarro-Zarza JE, Bucala R, Hernández-Bello J, Parra-Rojas I, Ramírez-Dueñas MG, García-Arellano S, Hernández-Palma LA, Machado-Sulbarán AC, Muñoz-Valle JF. Clin Rheumatol; 2019 Jun 01; 38(6):1643-1654. PubMed ID: 30747392 [Abstract] [Full Text] [Related]
16. Impact of Macrophage Migration Inhibitory Factor Gene Polymorphisms and Serum Macrophage Migration Inhibitory Factor Levels on Pulmonary and Spinal Tuberculosis Susceptibility: A Pooled Analysis. You SY, Zeng XB, Li N, Yang SK. Genet Test Mol Biomarkers; 2022 Sep 01; 26(9):430-442. PubMed ID: 36166743 [Abstract] [Full Text] [Related]
18. CATT polymorphism in MIF gene promoter is closely related to human pulmonary tuberculosis in a southwestern China population. Liu A, Bao F, Voravuthikunchai SP. Int J Immunopathol Pharmacol; 2018 Sep 01; 32():2058738418777108. PubMed ID: 29809055 [Abstract] [Full Text] [Related]
19. Influence of the MIF polymorphism -173G > C on Turkish postmenopausal women with osteoporosis. Ozsoy AZ, Karakus N, Tural S, Yigit S, Kara N, Alayli G, Tumer MK, Kuru O. Z Rheumatol; 2018 Sep 01; 77(7):629-632. PubMed ID: 28905103 [Abstract] [Full Text] [Related]
20. Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome. Karakaya B, van Moorsel CH, van der Helm-van Mil AH, Huizinga TW, Ruven HJ, van der Vis JJ, Grutters JC. Cytokine; 2014 Oct 01; 69(2):272-6. PubMed ID: 24951298 [Abstract] [Full Text] [Related] Page: [Next] [New Search]